Council Members in this Study Group: 114
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Leading institutions connect with members of this Study Group through GLG
Orthopaedic Surgeon
Hospital of the University of Pennsylvania - CC ![]()
Samir Mehta, MD, is an orthopaedic surgeon at the Hospital of the University of Pennsylvania. Previously, he was an Instructor at Harborview Medical Center and Orthopaedic Surgeon and Assistant Professor of Orthopaedic Surgery in the Division of Orthopaedic Trauma at the University of PennsylvaniaHealth...
Chief of Medical Staff
NorthEast Alabama Regional Medical Center ![]()
Gordon Hardy, MD, is the Chief of the Medical Staff at Northeast Alabama Regional Medical Center in Anniston, Alabama. He is a board certified Orthopaedic Surgeon and his practice involves a wide spectrum of orthopaedic surgery including adult reconstructive, sports medicine, hand, arthroscopic, knee,...
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
What's the big deal about "winning" Victory Pharma?
May 25, 2009
Gordon Hardy, Chief of Medical Staff , NorthEast Alabama Regional Medical Center
Sciele wins Victory Pharma | www.bizjournals.com
I am a board certified orthopaedic surgeon in active clinical practice involved the operative and nonoperative treatment of arthritis and other joint related conditions. I am familiar with the Victory Pharma product line as it relates to orthopaedics. Essentially, their products are recycledpharmaceuticals...
An also-ran in a crowded market
May 21, 2007
Zimmer Holdings and Regeneration Technologies Enter Distribution Agreement for New Allograft Paste Implant | www.pr-inside.com
Because bone void fillers are approved as devices, not drugs, they do not need to demonstrate efficacy, just safety. Orthopaedic surgeons are looking past bone void fillers to products that are more biologically active.
February 9, 2007
Smith & Nephew says court upholds injunction against Synthes | today.reuters.com
- Smith and Nephew's patent on intramedullary hip screws was upheld.- However, it is difficult to enforce and Synthes has not taken any products off of the market.
Hip resurfacing is small potatoes
February 9, 2007
Doctors Sell Hip Resurfacing to Boomers | www.nytimes.com
This article speculates that hip resurfacing will increase in popularity. Because traditional total hip arthroplasty is predictable, reliable, and safe, hip resurfacing will not capture more than 4-5% of the THA market.
Resurfacing expands market of joint replacement, slightly
January 22, 2007
More surgeons turning to resurfacing for DJD in baby boomers' hips and shoulders | www.orthosupersite.com
-Resurfacing is not new and will result in modest inroads into the market. -The HemiCAP from Arthrosurface expands surgical options in osteonecrosis of the shoulder and hip.
| Study Group Name | No. Members |
|---|---|
| Orthopedic Surgeons (US) | 960 |
| General Surgeons (US) | 464 |
| Physicians who Treat Sepsis (US) | 99 |
| Critical Care Physicians | 762 |
| Critical Care Physicians (US) | 345 |
| Bariatric Surgeons | 195 |
| Orthopedic Surgeons who Specialize in Hand Surgery (US) | 101 |
Leading Experts in Trauma Surgeons (US) Study Group have not participated in any upcoming seminars.
View All GLG Live Meetings in Healthcare
Leading Experts in Trauma Surgeons (US) have not participated in any GLG webcasts.